EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 128 filers reported holding EXELIXIS INC in Q4 2014. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $4,941,000 | +12.3% | 331,399 | -3.6% | 0.01% | 0.0% |
Q3 2016 | $4,399,000 | +133.9% | 343,947 | +42.8% | 0.01% | +150.0% |
Q2 2016 | $1,881,000 | +121.8% | 240,827 | +13.6% | 0.00% | +100.0% |
Q1 2016 | $848,000 | -26.7% | 211,962 | +3.3% | 0.00% | 0.0% |
Q4 2015 | $1,157,000 | -17.7% | 205,117 | -18.1% | 0.00% | -50.0% |
Q3 2015 | $1,405,000 | +182.7% | 250,519 | +89.5% | 0.00% | +100.0% |
Q2 2015 | $497,000 | +51.5% | 132,221 | +3.7% | 0.00% | – |
Q1 2015 | $328,000 | +111.6% | 127,556 | +18.8% | 0.00% | – |
Q4 2014 | $155,000 | -90.1% | 107,412 | -89.5% | 0.00% | -100.0% |
Q3 2014 | $1,558,000 | -66.8% | 1,018,472 | -26.5% | 0.00% | -50.0% |
Q2 2014 | $4,699,000 | +98.5% | 1,386,016 | +107.3% | 0.00% | +100.0% |
Q1 2014 | $2,367,000 | -62.2% | 668,617 | -34.6% | 0.00% | -66.7% |
Q4 2013 | $6,264,000 | -5.5% | 1,021,823 | -10.3% | 0.01% | -14.3% |
Q3 2013 | $6,631,000 | +28.4% | 1,139,414 | +0.2% | 0.01% | +40.0% |
Q2 2013 | $5,164,000 | – | 1,137,523 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 6,816,300 | $106,879,000 | 71.10% |
Krensavage Asset Management, LLC | 1,821,475 | $28,561,000 | 9.09% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 543,000 | $8,509,000 | 2.73% |
CAPITAL MANAGEMENT CORP /VA | 508,493 | $7,973,000 | 2.25% |
SECTORAL ASSET MANAGEMENT INC | 553,375 | $8,677,000 | 1.71% |
Sargent Investment Group, LLC | 282,860 | $4,413,000 | 1.37% |
Stephens Investment Management Group LLC | 4,073,211 | $63,868,000 | 1.21% |
Boxer Capital, LLC | 1,250,000 | $19,600,000 | 1.10% |
Lingohr Asset Management GmbH | 22,493 | $373,000 | 1.02% |
FARALLON CAPITAL MANAGEMENT LLC | 10,675,844 | $167,397,000 | 0.93% |